Genus Pharmaceuticals

Park View House, 65 London Road, Newbury, Berkshire, RG14 1JN
Telephone: +44 (0)1635 568 400
Fax: +44 (0)1635 568 401
Medical Information Direct Line: +44 (0)870 851 0207
Medical Information e-mail: genus@medinformation.co.uk
Customer Care direct line: +44 (0)1635 568 445
Medical Information Fax: +44 (0)1793 710 387

Patient Information Leaflet last updated on the eMC: 07/02/2012
PIL APO-go PFS 5mg/ml Solution for Infusion in Pre-filled Syringe

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change of manufacturer
  • Change to manufacturer contact details
Updated on 28/09/2010 and displayed until 07/02/2012
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 09/03/2010 and displayed until 28/09/2010
Reasons for adding or updating:
  • Change of contra-indications
  • Change to warnings or special precautions for use
Updated on 03/02/2010 and displayed until 09/03/2010
Reasons for adding or updating:
  • Change of manufacturer
  • Change to Marketing Authorisation Holder
Updated on 18/09/2009 and displayed until 03/02/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
Updated on 04/09/2009 and displayed until 18/09/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 18/02/2009 and displayed until 04/09/2009
Reasons for adding or updating:
  • Change of manufacturer
  • PIL Retired pending re-submission
Updated on 26/08/2008 and displayed until 18/02/2009
Reasons for adding or updating:
  • Change of manufacturer
Updated on 01/07/2008 and displayed until 26/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Improved Electronic Presentation
Updated on 12/05/2006 and displayed until 01/07/2008
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 25/05/2005 and displayed until 12/05/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 04/05/2005 and displayed until 25/05/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 29/04/2005 and displayed until 04/05/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   apomorphine hydrochloride